$42.37
-0.430 (-1.00%)
At Close: Jun 03, 2026
Hydroxychloroquine Sulphate Market Recent Trends, Future Growth Analysis Forecasts 2027|Sanofi, Novartis, Shanghai Zhongxisanwei
02:44pm, Wednesday, 24'th Nov 2021 OpenPR
The global Hydroxychloroquine Sulphate market was valued at 734.3 Million USD in 2020 and will grow with a CAGR of 1.86% from 2021 to 2027. The report covers critical subtleties on the key makers, crucial market sections, item advancement scope,
Antiemetics Market 2021 New Innovations, Research, Key Business Strategies, Current Trend by Top Players Baxter, Pfizer, Astellas, Merck, Sanofi
07:01am, Wednesday, 24'th Nov 2021 OpenPR
Antiemetics are medications that work for vomiting and nausea. Antiemetics are commonly used to treat motion sickness and opioid pain relievers, general anesthetics, and side effects of chemotherapy for cancer. The Global Antiemetics Industry Report is an in-depth study analyzing
Glucagon Like Peptide-1 (GLP-1) Agonists Market 2021 Analysis by Top Manufacturers| Novo Nordisk, AstraZeneca, Eli Lilly, GSK, Sanofi, Bristol-Myers Squibb, Amylin
05:25am, Wednesday, 24'th Nov 2021 OpenPR
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Insights and Forecast to 2027 Glucagon Like Peptide-1 (GLP-1) Agonists Market research performs thorough market analysis and uses a variety of sources to provide key players with wide-ranging knowledge about industry strategies. This analysis
A new market study, titled “Discover Hydroxychloroquine Market By Upcoming Trends, Growth Drivers and Challenges” has been featured on Fortune Business Insights™. ***Get Latest Updated Market Research Report with Sample Report Market Overview: The global hydroxychloroquine market size is projected to reach USD
Baidu Partners with Sanofi on Vaccine Development
11:14am, Tuesday, 23'rd Nov 2021 Smarter Analyst
Baidu (BIDU) has achieved a significant milestone as it seeks to leverage computational biology strengths in enhancing mRNA vaccine and therapy designs. The The post Baidu Partners with Sanofi on Vaccine Development appeared first on Smarter Analyst .
Global Influenza Vaccine Market 2021-2028 Size, Share, Growth Factors, Competitive Landscape, Revenue, Forecast Report
09:31am, Tuesday, 23'rd Nov 2021 Intrado Digital Media
Key Companies in Influenza Vaccine Market are GlaxoSmithKline plc, Sanofi S.A, AstraZeneca, Seqirus, BioDiem, Emergent Bio Solutions Inc, Sinovac Biotech Ltd, Other Prominent Players Key Companies in Influenza Vaccine Market are GlaxoSmithKline plc, Sanofi S.A, AstraZeneca, Seqirus, BioDiem, Emergent Bio Solutions Inc, Sinovac Biotech Ltd, Other Prominent Players
Stomatitis Market SWOT Analysis, Key Indicators and Top Key Vendors (J&J, GSK, Allergan, Pfizer, Abbott, Roche, Teva, Sanofi) | Forecast to 2028
09:06am, Tuesday, 23'rd Nov 2021 OpenPR
Overview of Global Stomatitis Market: The research and analysis carried out in the winning Stomatitis Market report helps clients to predict investment in an emerging market, expansion of market share or success of a new product with the help of global
Injection Pen Market research report gives a thorough idea about the current scenario of the global market, recent developments, product launches, joint ventures, capacity, production value, mergers, and acquisitions based on several market dynamics. It gives key measurements, the status
Sinusitis Drugs Market May Set New Growth Story | Sanofi, Merck & Co. Inc., GlaxoSmithKline Plc., Intersect ENT Inc.
05:17am, Tuesday, 23'rd Nov 2021 OpenPR
Global Sinusitis Drugs Market: Snapshot The sinusitis drugs market has been expected to experience significant growth opportunities in the forthcoming years. This market growth is on the back of an increasing number of respiratory tract infections and growing cases of chronic
Baidu Licenses Its Algorithm To Sanofi For mRNA Vaccine, Therapy Development
03:24pm, Monday, 22'nd Nov 2021 Benzinga
Baidu Inc (NASDAQ: BIDU ) has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA (NASDAQ: SNY ) for use in designing vaccine and therapeutic products. The deal marks Baidu''s first such commercial deal with a major global drugmaker. Also Read: Sanofi Stops Work On Its mRNA COVID-19 Vaccine: What You Full story available on Benzinga.com
Baidu partners Sanofi on mRNA vaccine and therapy development
01:34pm, Monday, 22'nd Nov 2021 PageOne Nigeria
Chinese tech giant Baidu Inc has licensed its algorithm for The post Baidu partners Sanofi on mRNA vaccine and therapy development appeared first on PageOne .
Sanofi and Baidu ink license agreement for next-gen mRNA therapies and vaccines
12:26pm, Monday, 22'nd Nov 2021 Seeking AlphaBaidu, Sanofi Ink License Deal To Integrate Baidu''s Design Into Sanofi''s Product Design Pipeline
12:20pm, Monday, 22'nd Nov 2021 Business Insider Markets
(RTTNews) - AI company Baidu.com, Inc. (BIDU) and French drug major Sanofi (SNYNF, SNY) have entered into an agreement to integrate Baidu''s messenger ribonucleic acid (mRNA) design optimization platform, LinearDesign, into Sanofi''s product design pipeline. Under the agreement, Sanofi will leverage the LinearDesign platform to contribute to the…
Baidu Licenses Its Algorithm To Sanofi For mRNA Vaccine, Therapy Development
10:24am, Monday, 22'nd Nov 2021
Baidu Inc (NASDAQ: BIDU) has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA (NASDAQ: SNY) for use in designing vaccine and therapeutic products. The deal marks Baidu's firs
Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development
07:09am, Monday, 22'nd Nov 2021
Chinese tech giant Baidu Inc said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such
Sign In
Buy SNY